APPLICATION
NDA010012
TYPE
NDA
LATEST ACTION
1983-07-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
SANDRILDiscontinued
RESERPINE 2.5MG/ML · INJECTABLE · INJECTION
Approval history
1983-07-20Labeling · Supplement 6AP
1981-10-22Manufacturing (CMC) · Supplement 4 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.